Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Arcaini

Showing results (61-70 of 262) with videos related to

Pageof 27
Sort By:
Hematological Oncology|April 23, 2024
Future perspectives of radiation therapy for Hodgkin Lymphoma: Risk-adapted, response-adapted, and safer than beforeJessica Saddi, Amelia Barcellini, Manuel Gotti, et al.
Research and Practice in Thrombosis and Haemostasis|March 31, 2023
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasmsOscar Borsani, Virginia V Ferretti, Ilaria C Casetti, et al.
Annals of Hematology|September 6, 2025
Unicentric Castleman disease treated with rituximab before surgery: clinicopathologic findingsMarco Paulli, Giuseppe Neri, Francesca Antoci, et al.
Clinical Lymphoma & Myeloma|July 11, 2007
An insidious presentation of splenic marginal zone lymphomaSara Burcheri, Luca Arcaini, Matteo Della Porta, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 11, 2014
Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma)Corrado Tarella, Luca Arcaini, Luca Baldini, et al.
Haematologica|January 29, 2003
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemiaFrancesco Passamonti, Lucia Malabarba, Ester Orlandi, et al.
American Journal of Hematology|August 20, 2009
Blast phase of essential thrombocythemia: A single center studyFrancesco Passamonti, Elisa Rumi, Luca Arcaini, et al.
International Journal of Cancer|January 10, 2009
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infectionLuca Arcaini, Cristiana Pascutto, Francesco Passamonti, et al.
Blood|September 28, 2013
MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significanceMarzia Varettoni, Silvia Zibellini, Luca Arcaini, et al.
Therapeutic Drug Monitoring|November 25, 2005
Pharmacokinetic behavior of rituximab: a study of different schedules of administration for heterogeneous clinical settingsMario B Regazzi, Isabella Iacona, Maria Antonietta Avanzini, et al.
Pageof 27

Showing results (61-70 of 262) with videos related to

Sort By:
Pageof 27
Hematological Oncology|April 23, 2024
Future perspectives of radiation therapy for Hodgkin Lymphoma: Risk-adapted, response-adapted, and safer than beforeJessica Saddi, Amelia Barcellini, Manuel Gotti, et al.
Research and Practice in Thrombosis and Haemostasis|March 31, 2023
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasmsOscar Borsani, Virginia V Ferretti, Ilaria C Casetti, et al.
Annals of Hematology|September 6, 2025
Unicentric Castleman disease treated with rituximab before surgery: clinicopathologic findingsMarco Paulli, Giuseppe Neri, Francesca Antoci, et al.
Clinical Lymphoma & Myeloma|July 11, 2007
An insidious presentation of splenic marginal zone lymphomaSara Burcheri, Luca Arcaini, Matteo Della Porta, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 11, 2014
Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma)Corrado Tarella, Luca Arcaini, Luca Baldini, et al.
Haematologica|January 29, 2003
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemiaFrancesco Passamonti, Lucia Malabarba, Ester Orlandi, et al.
American Journal of Hematology|August 20, 2009
Blast phase of essential thrombocythemia: A single center studyFrancesco Passamonti, Elisa Rumi, Luca Arcaini, et al.
International Journal of Cancer|January 10, 2009
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infectionLuca Arcaini, Cristiana Pascutto, Francesco Passamonti, et al.
Blood|September 28, 2013
MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significanceMarzia Varettoni, Silvia Zibellini, Luca Arcaini, et al.
Therapeutic Drug Monitoring|November 25, 2005
Pharmacokinetic behavior of rituximab: a study of different schedules of administration for heterogeneous clinical settingsMario B Regazzi, Isabella Iacona, Maria Antonietta Avanzini, et al.
Pageof 27